Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Change in Acquisitions & Divestments (2019 - 2026)

Intellia Therapeutics has reported Change in Acquisitions & Divestments over the past 8 years, most recently at $113.4 million for Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 36.42% to $113.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $486.8 million through Mar 2026, down 50.19% year-over-year, with the annual reading at $551.7 million for FY2025, 48.29% down from the prior year.
  • Change in Acquisitions & Divestments was $113.4 million for Q1 2026 at Intellia Therapeutics, up from $94.7 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $321.6 million in Q4 2024 and troughed at $93.7 million in Q1 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $199.7 million (2024), against an average of $192.2 million.
  • Year-over-year, Change in Acquisitions & Divestments surged 181.24% in 2023 and then plummeted 70.55% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $210.2 million in 2022, then decreased by 6.17% to $197.2 million in 2023, then soared by 63.08% to $321.6 million in 2024, then plummeted by 70.55% to $94.7 million in 2025, then grew by 19.69% to $113.4 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Change in Acquisitions & Divestments are $113.4 million (Q1 2026), $94.7 million (Q4 2025), and $115.9 million (Q3 2025).